ANGO
NASDAQAngioDynamics
$11.23
-2.96 (-20.86%)
2026-10-08 00:00
Healthcare
Medical Instruments & Supplies
--
--
Short Interest (1 Year)
% of Volume Sold ShortMarket Cap
$637.3M
P/E Ratio
N/A
52W Low
52W High
$9.39
$16.29
Volume
3.1M
Analyst Rating
Hold
Target: $19
9 Analyst Ratings
Strong Buy
0
Buy
0
Hold
9
Sell
0
Price Target Range
Low: $18
Avg: $19
High: $20
About AngioDynamics
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombec...
Employees
632
Website
angiodynamics.com
Financial Highlights
Annual
Quarterly
| Year | Revenue | Op Margin | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2026 | $320.2M | -12.5% | -$36.7M | $5.7M |
| 2025 | $292.5M | -13.7% | -$34.0M | -$5.7M |
| 2024 | $303.9M | -63.3% | -$184.3M | -$22.4M |
| 2023 | $338.8M | -15.1% | -$52.4M | $4.4M |
| 2022 | $316.2M | -9.0% | -$26.5M | -$2.9M |
| 2026 Q2 | $86.6M | -23.5% | -$11.4M | $17.9M |
| 2026 Q1 | $78.4M | -8.2% | -$8.1M | -$2.1M |
| 2025 Q4 | $79.4M | -3.1% | -$6.3M | $5.1M |
| 2025 Q3 | $75.7M | -14.1% | -$10.9M | -$15.2M |
| 2025 Q2 | $80.2M | -7.2% | -$6.0M | $19.6M |
| 2025 Q1 | $72.0M | -13.9% | -$4.4M | -$11.4M |
| 2024 Q4 | $72.8M | -15.2% | -$10.7M | $3.3M |
| 2024 Q3 | $67.5M | -19.4% | -$12.8M | -$17.2M |